JP2024522692A5 - - Google Patents

Info

Publication number
JP2024522692A5
JP2024522692A5 JP2023577160A JP2023577160A JP2024522692A5 JP 2024522692 A5 JP2024522692 A5 JP 2024522692A5 JP 2023577160 A JP2023577160 A JP 2023577160A JP 2023577160 A JP2023577160 A JP 2023577160A JP 2024522692 A5 JP2024522692 A5 JP 2024522692A5
Authority
JP
Japan
Prior art keywords
lipid
alkyl
pharmaceutically acceptable
acceptable salt
peg
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023577160A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024522692A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/033334 external-priority patent/WO2022266032A1/en
Publication of JP2024522692A publication Critical patent/JP2024522692A/ja
Publication of JP2024522692A5 publication Critical patent/JP2024522692A5/ja
Pending legal-status Critical Current

Links

JP2023577160A 2021-06-14 2022-06-14 カチオン性脂質及びその組成物 Pending JP2024522692A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163210204P 2021-06-14 2021-06-14
US63/210,204 2021-06-14
PCT/US2022/033334 WO2022266032A1 (en) 2021-06-14 2022-06-14 Cationic lipids and compositions thereof

Publications (2)

Publication Number Publication Date
JP2024522692A JP2024522692A (ja) 2024-06-21
JP2024522692A5 true JP2024522692A5 (cg-RX-API-DMAC7.html) 2025-06-24

Family

ID=82547431

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023577160A Pending JP2024522692A (ja) 2021-06-14 2022-06-14 カチオン性脂質及びその組成物

Country Status (10)

Country Link
US (1) US20240293574A1 (cg-RX-API-DMAC7.html)
EP (1) EP4355727A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024522692A (cg-RX-API-DMAC7.html)
KR (1) KR20240023420A (cg-RX-API-DMAC7.html)
CN (2) CN117642380A (cg-RX-API-DMAC7.html)
AU (1) AU2022291742A1 (cg-RX-API-DMAC7.html)
CA (1) CA3222589A1 (cg-RX-API-DMAC7.html)
IL (1) IL309145A (cg-RX-API-DMAC7.html)
MX (1) MX2023014855A (cg-RX-API-DMAC7.html)
WO (1) WO2022266032A1 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116082184B (zh) * 2023-04-12 2023-06-30 山东大学 基于环己二胺的可电离脂质、脂质纳米颗粒及其制备方法与应用
EP4719352A1 (en) 2023-05-31 2026-04-08 Capstan Therapeutics, Inc. Lipid nanoparticle formulations and compositions
WO2025005632A1 (ko) * 2023-06-26 2025-01-02 주식회사 무진메디 이온화 가능한 펩타이드를 이용한 지질 나노입자 기반 약물 전달체 및 이의 제조방법
KR102898792B1 (ko) * 2023-06-26 2025-12-19 주식회사 무진메디 이온화 가능한 펩타이드를 이용한 지질 나노입자 기반 약물 전달체 및 이의 제조방법
AU2024413489A1 (en) * 2023-12-29 2026-07-16 Samyang Biopharm Corporation Nanoparticle composition for drug delivery
CN117964577B (zh) * 2024-03-29 2024-06-21 天津全和诚生物技术有限公司 阳离子脂质化合物、其制备方法、包含其的组合物及应用
WO2026003582A2 (en) 2024-06-27 2026-01-02 Axelyf ehf. Lipids and lipid nanoparticles
CN118634207B (zh) * 2024-08-15 2024-11-26 北京悦康科创医药科技股份有限公司 一种雾化吸入用核酸-脂质纳米粒及其制备方法和应用
CN118903476B (zh) * 2024-10-10 2025-05-06 嘉晨西海(南昌)生物制药有限公司 含LNP和mRNA的组合物及其在治疗戈谢病中的应用

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US5885613A (en) 1994-09-30 1999-03-23 The University Of British Columbia Bilayer stabilizing components and their use in forming programmable fusogenic liposomes
US5928906A (en) 1996-05-09 1999-07-27 Sequenom, Inc. Process for direct sequencing during template amplification
CA2289702C (en) 1997-05-14 2008-02-19 Inex Pharmaceuticals Corp. High efficiency encapsulation of charged therapeutic agents in lipid vesicles
AU6814901A (en) 2000-06-01 2001-12-11 Univ North Carolina Methods and compounds for controlled release of recombinant parvovirus vectors
WO2002087541A1 (en) 2001-04-30 2002-11-07 Protiva Biotherapeutics Inc. Lipid-based formulations for gene transfer
EP1519714B1 (en) 2002-06-28 2010-10-20 Protiva Biotherapeutics Inc. Method and apparatus for producing liposomes
CN1882693B (zh) 2003-09-15 2012-08-15 普洛体维生物治疗公司 聚乙二醇修饰的脂质化合物及其应用
US7404969B2 (en) 2005-02-14 2008-07-29 Sirna Therapeutics, Inc. Lipid nanoparticle based compositions and methods for the delivery of biologically active molecules
JP5639338B2 (ja) 2005-07-27 2014-12-10 プロチバ バイオセラピューティクス インコーポレイティッド リポソームの製造システムおよび製造方法
WO2008103276A2 (en) 2007-02-16 2008-08-28 Merck & Co., Inc. Compositions and methods for potentiated activity of biologicaly active molecules
EP3100718B1 (en) 2008-01-02 2019-11-27 Arbutus Biopharma Corporation Improved compositions and methods for the delivery of nucleic acids
EP2279254B1 (en) 2008-04-15 2017-07-05 Protiva Biotherapeutics Inc. Novel lipid formulations for nucleic acid delivery
EP3391877A1 (en) 2010-04-08 2018-10-24 The Trustees of Princeton University Preparation of lipid nanoparticles
WO2011139911A2 (en) 2010-04-29 2011-11-10 Isis Pharmaceuticals, Inc. Lipid formulated single stranded rna
US20120225129A1 (en) 2010-08-20 2012-09-06 Cerulean Pharma Inc. Conjugates, particles, compositions, and related methods
CA2853689C (en) 2011-11-04 2020-06-30 Nitto Denko Corporation Method of producing lipid nanoparticles for drug delivery
TWI595885B (zh) 2012-05-02 2017-08-21 喜納製藥公司 包含四galnac之新穎結合物及傳送寡核苷酸之方法
CN105085292B (zh) * 2014-05-23 2017-12-15 上海交通大学 3‑((2‑(二甲氨基)乙烷基)(甲基)氨基)丙酸的两亲性衍生物及其用途
HUE067372T2 (hu) 2015-06-29 2024-10-28 Acuitas Therapeutics Inc Lipidek és nanoszemcsés lipid formulázások nukleinsavak beadására
HRP20220156T1 (hr) 2015-09-17 2022-04-15 Modernatx, Inc. Spojevi i pripravci za unutarstaničnu isporuku terapeutskih sredstava
CN108368028B (zh) 2015-10-28 2021-09-03 爱康泰生治疗公司 用于递送核酸的新型脂质和脂质纳米颗粒制剂
WO2017084987A1 (en) 2015-11-16 2017-05-26 F. Hoffmann-La Roche Ag GalNAc CLUSTER PHOSPHORAMIDITE
DK3386484T3 (da) 2015-12-10 2022-07-04 Modernatx Inc Sammensætninger og fremgangsmåder til afgivelse af terapeutiske midler
AU2017268396B2 (en) * 2016-05-18 2023-05-18 Modernatx, Inc. Polynucleotides encoding citrin for the treatment of citrullinemia type 2
RS63625B1 (sr) * 2016-05-18 2022-10-31 Modernatx Inc Kombinacije irnk koje kodiraju imunomodulirajuće polipeptide i njihova upotreba
RS63953B1 (sr) * 2017-03-15 2023-02-28 Modernatx Inc Jedinjenje i kompozicije za intracelularnu isporuku terapeutskih sredstava
JP7630904B2 (ja) * 2019-07-23 2025-02-18 株式会社東芝 核酸導入キャリア、核酸導入キャリアセット、核酸導入組成物及び核酸導入方法
CN114929205B (zh) * 2019-09-06 2024-09-03 世代生物公司 包括末端封闭式dna和可切割脂质的脂质纳米颗粒组合物及其使用方法
WO2021092194A1 (en) * 2019-11-05 2021-05-14 Vicarious Surgical Inc. Surgical virtual reality user interface
AU2020385378A1 (en) * 2019-11-22 2022-04-07 Generation Bio Co. Ionizable lipids and nanoparticle compositions thereof
WO2022006368A2 (en) * 2020-07-02 2022-01-06 Life Technologies Corporation Trinucleotide cap analogs, preparation and uses thereof
AU2021307952A1 (en) * 2020-07-17 2023-03-02 Generation Bio Co. Methods for encapsulating polynucleotides into reduced sizes of Lipid nanoparticles and novel formulation thereof

Similar Documents

Publication Publication Date Title
JP2023502576A5 (cg-RX-API-DMAC7.html)
JP2023518985A5 (cg-RX-API-DMAC7.html)
JP2024517644A5 (cg-RX-API-DMAC7.html)
JP2022546597A5 (cg-RX-API-DMAC7.html)
JP2023534043A5 (cg-RX-API-DMAC7.html)
US12252470B2 (en) Lipids and nanoparticle compositions thereof
KR20230052895A (ko) 폴리뉴클레오타이드를 감소된 크기의 지질 나노입자로 캡슐화하는 방법 및 신규한 지질 나노입자 제형
JP2023527747A5 (cg-RX-API-DMAC7.html)
US20240293574A1 (en) Cationic lipids and compositions thereof
US20240226325A1 (en) Cationic lipids and compositions thereof
JP2024520756A5 (cg-RX-API-DMAC7.html)
US20230181764A1 (en) Novel lipids and nanoparticle compositions thereof
JP2024529343A5 (cg-RX-API-DMAC7.html)
RU2023129760A (ru) Катионные липиды и их композиции
RU2023135629A (ru) Катионные липиды и их композиции